- Home
- SLDB vs HNST Comparison
SLDB vs HNST Comparison
Compare SLDB & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- HNST
- Stock Information
- Founded
- SLDB 2013
- HNST 2012
- Country
- SLDB United States
- HNST United States
- Employees
- SLDB N/A
- HNST N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- HNST Catalog/Specialty Distribution
- Sector
- SLDB Health Care
- HNST Consumer Discretionary
- Exchange
- SLDB Nasdaq
- HNST Nasdaq
- Market Cap
- SLDB 529.4M
- HNST 500.5M
- IPO Year
- SLDB 2018
- HNST 2021
- Fundamental
- Price
- SLDB $6.11
- HNST $3.83
- Analyst Decision
- SLDB Strong Buy
- HNST Buy
- Analyst Count
- SLDB 10
- HNST 5
- Target Price
- SLDB $15.00
- HNST $6.75
- AVG Volume (30 Days)
- SLDB 1.4M
- HNST 4.6M
- Earning Date
- SLDB 08-12-2025
- HNST 08-06-2025
- Dividend Yield
- SLDB N/A
- HNST N/A
- EPS Growth
- SLDB N/A
- HNST N/A
- EPS
- SLDB N/A
- HNST 0.06
- Revenue
- SLDB N/A
- HNST $389,783,000.00
- Revenue This Year
- SLDB N/A
- HNST $7.07
- Revenue Next Year
- SLDB N/A
- HNST $4.90
- P/E Ratio
- SLDB N/A
- HNST $63.05
- Revenue Growth
- SLDB N/A
- HNST 9.58
- 52 Week Low
- SLDB $2.41
- HNST $3.32
- 52 Week High
- SLDB $10.37
- HNST $8.97
- Technical
- Relative Strength Index (RSI)
- SLDB 49.25
- HNST 34.12
- Support Level
- SLDB $5.87
- HNST $3.78
- Resistance Level
- SLDB $6.81
- HNST $4.05
- Average True Range (ATR)
- SLDB 0.46
- HNST 0.24
- MACD
- SLDB -0.14
- HNST -0.06
- Stochastic Oscillator
- SLDB 22.22
- HNST 23.57
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.